Oxaloplatino [Spanish]
Oxaloplatino [Spanish] Brand names, Oxaloplatino [Spanish] Analogs
Oxaloplatino [Spanish] Brand Names Mixture
- No information avaliable
Oxaloplatino [Spanish] Chemical_Formula
Oxaloplatino [Spanish] RX_link
Oxaloplatino [Spanish] fda sheet
Oxaloplatino [Spanish] msds (material safety sheet)
Oxaloplatino [Spanish] Synthesis Reference
Oxaloplatino [Spanish] Molecular Weight
Oxaloplatino [Spanish] Melting Point
Oxaloplatino [Spanish] H2O Solubility
Oxaloplatino [Spanish] State
Oxaloplatino [Spanish] LogP
Oxaloplatino [Spanish] Dosage Forms
Oxaloplatino [Spanish] Indication
Oxaloplatino [Spanish] Pharmacology
Oxaloplatino [Spanish] Absorption
Oxaloplatino [Spanish] side effects and Toxicity
Oxaloplatino [Spanish] Patient Information
Patients and patientsí caregivers should be informed of the expected side effects of ELOXATIN, particularly its neurologic effects, both the acute, reversible effects, and the persistent neurosensory toxicity. Patients should be informed that the acute neurosensory toxicity may be precipitated or exacerbated by exposure to cold or cold objects. Patients should be instructed to avoid cold drinks, use of ice, and should cover exposed skin prior to exposure to cold temperature or cold objects.
Patients must be adequately informed of the risk of low blood cell counts and instructed to contact their physician immediately should fever, particularly if associated with persistent diarrhea, or evidence of infection develop.
Patients should be instructed to contact their physician if persistent vomiting, diarrhea, signs of dehydration, cough or breathing difficulties occur, or signs of allergic reaction appear.
![Oxaloplatino_[Spanish]](/images/rx/APRD00186.gif)
